People: Vitrolife AB (VITRO.BE)

VITRO.BE on Berlin Stock Exchange

30 Apr 2015
Change (% chg)

€-0.63 (-3.65%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Axelsson, Thomas 

Mr. Thomas Axelsson has served as Chief Executive Officer (CEO) of Vitrolife AB since November 17, 2011. He was, among other things, CEO of Stille and Artema. Currently, he is Member of the Board of Directors at MedCap AB. He has been Chairman of the Board of Directors at Dipylon Medical AB (previously CMA Microdialysis AB) and Airsonett AB, among others. He holds a Master of Science degree.

Basic Compensation

Total Annual Compensation, SEK Long-Term Incentive Plans, SEK All Other, SEK Fiscal Year Total, SEK
3,741,000 -- -- 3,741,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks